⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 22, 2010BMJ

Health technology assessments: what do differing conclusions tell us?

Finn Børlum Kristensen Ansgar Gerhardus

View at Publisher

Ask AI

Bookmark

Share

Abstract

Analysis of national decisions on HPV vaccination shows the value of greater exchange, agreement on core methods, and increased collaboration between Europe’s health technology assessment agencies, say Finn Børlum Kristensen and Ansgar Gerhardus

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kristensen et al. (2010) studied this question.

synapsesocial.com/papers/6a8b9f290c58d86fb4cacd53 https://doi.org/10.1136/bmj.c5236

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Confidence intervals and statistical significanceBMJ · 2012
2Cameron launches challenge to end "national crisis" of poor dementia careBMJ · 2012
3How good is the science?BMJ · 2012
4Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial dataBMJ · 2012
5Antimuscarinic drugs to treat overactive bladderBMJ · 2012

Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort studyBMJ · 2012
Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trialENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2012
Minimum unit price for alcohol is planned for England and WalesBMJ · 2012
Health literacyBMJ · 2012
How the FDA forgot the evidence: the case of donepezil 23 mgBMJ · 2012

More from University of Southern Denmark

More from Bielefeld University

More from National Board of Health